Answers to common questions about MigraClarity and about migraine as a condition. If you have a question that isn't answered here, reach out through our contact page.
Yes. MigraClarity is free to start. The free plan includes unlimited attack logging, trigger tracking, gender-aware onboarding, basic pattern insights, treatment efficacy tracking, a 7-day barometric pressure forecast and data export (CSV/PDF). Pro adds a doctor report PDF with shareable link, a 7-day migraine risk calendar, day-of-week and cycle-phase insights, top triggers and trigger combinations, voice logging, medication inventory and cloud sync. The free plan may include ads; paid plans are ad-free.
No download is required to use MigraClarity — it runs directly in your browser at migraclarity.com. If you'd prefer a native app experience, MigraClarity is also available on Google Play.
Yes. Your attack logs, symptoms, and personal health information are stored securely and are never sold or shared with third parties for advertising purposes. See our Privacy Policy for full details on how your data is handled.
MigraClarity asks new users to select a gender mode because migraine presents differently and is driven by different biological mechanisms in women and men. Female mode tracks your cycle phase alongside each attack and, with Pro, shows luteal phase pattern insights. Male mode emphasizes sleep, exertion, and stress, the trigger categories most clinically relevant to men. This shapes what the app tracks and what appears in your doctor report.
No. MigraClarity is a tracking and reporting tool, not a diagnostic device or a substitute for medical care. It helps you collect accurate, structured data about your condition so that conversations with your doctor or neurologist are more productive. Diagnosis and treatment decisions should always be made by a qualified healthcare professional.
The app is available in English and Spanish. Resource library articles are in English, with a Google Translate option for other languages.
When you allow location access, MigraClarity pulls real-time and forecasted barometric pressure data for your location and shows a 7-day pressure forecast on your dashboard. With Pro, the 7-day migraine risk calendar is based on your logged attacks, cycle phase, daily check-ins and the barometric pressure forecast. It describes patterns in your own logs and is not a medical prediction.
The doctor report is a Pro feature. It is a PDF summarized against ICHD-3 diagnostic criteria for migraine without aura, covering an ICHD-3 headache diary summary, medication use pattern, attack overview, top triggers, treatment efficacy and an attack log, plus the hormonal pattern for users in female mode. You can also create a shareable link to it, which expires after 7 days.
Migraine is a neurological disorder, not simply a severe headache. It typically involves moderate to severe, often one-sided, throbbing pain that worsens with activity, along with associated symptoms such as nausea and sensitivity to light and sound. A tension headache, by contrast, usually produces mild to moderate, band-like pressure without those associated symptoms.
Migraine affects approximately one in seven people worldwide and is the second leading cause of years lived with disability globally, according to the World Health Organization. Women are affected about two to three times more often than men.
There is currently no cure for migraine, but it can be effectively managed. Acute treatments reduce the severity and duration of individual attacks, while preventive treatments, both pharmacological and behavioral, can meaningfully reduce how often attacks occur. Many people achieve significant improvement in quality of life with an appropriate, individualized treatment plan.
You should seek medical evaluation for headaches that are frequent, severe, disabling, or that have changed in pattern. Seek immediate emergency care for a sudden, severe headache unlike any you have had before, a headache with fever and neck stiffness, or a headache accompanied by new neurological symptoms such as weakness, confusion, or vision loss.
Genetics play a significant role. Research published in Neurology has found that first-degree relatives of people with migraine are two to four times more likely to develop the condition themselves. However, genetics create susceptibility; environmental and physiological triggers determine when and whether attacks actually occur.
Yes. Migraine affects approximately ten percent of school-age children and up to twenty-eight percent of teenagers. Pediatric migraine often differs from the adult presentation, including shorter attack duration and more frequently bilateral pain.
Migraine with aura involves reversible neurological symptoms, most often visual disturbances, that typically precede the headache phase and develop gradually over five or more minutes before resolving within an hour. Migraine without aura does not include these symptoms. Roughly thirty percent of people with migraine experience aura, at least occasionally.
The information on this page is intended for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional or licensed physician before making any decisions about your health, medications, or treatment. MigraClarity is not a medical provider and nothing on this site should be used as a substitute for professional medical care.